Challenges and resistance mechanisms to EGFR targeted therapies in head and neck cancers and breast cancer: Insights into RTK dependent and independent mechanisms
Oncotarget · 25.06.2025 · 16 (1) · 508-530
DOI: 10.18632/oncotarget.28747 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncotarget, online erschienen am 25.06.2025. Verfasst von Shreya Shyamsunder und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Cincinnati Medical Center, Cincinnati, OH 45267, USA. Hauptthemen laut MEDLINE: ErbB Receptors, Drug Resistance, Neoplasm, Breast Neoplasms, Head and Neck Neoplasms. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, University of Cincinnati Medical Center, Cincinnati, OH 45267, USA.
- Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
- Research Service, Cincinnati Veterans Affairs Medical Center, Cincinnati, OH 45220, USA.
Förderung
- BLRD VA
- NCI NIH HHS
Zitieren
APA
Shyamsunder, S., Lu, Z., Takiar, V., & Waltz, S. E. (2025). Challenges and resistance mechanisms to EGFR targeted therapies in head and neck cancers and breast cancer: Insights into RTK dependent and independent mechanisms. Oncotarget, 16(1), 508-530. https://doi.org/10.18632/oncotarget.28747
Vancouver
Shyamsunder S, Lu Z, Takiar V, Waltz SE. Challenges and resistance mechanisms to EGFR targeted therapies in head and neck cancers and breast cancer: Insights into RTK dependent and independent mechanisms. Oncotarget. 2025;16(1):508-530. doi:10.18632/oncotarget.28747
BibTeX
@article{Shyamsunder2025,
author = {Shyamsunder, Shreya and Lu, Zhixin and Takiar, Vinita and Waltz, Susan E},
title = {Challenges and resistance mechanisms to EGFR targeted therapies in head and neck cancers and breast cancer: Insights into RTK dependent and independent mechanisms},
journal = {Oncotarget},
year = {2025},
volume = {16},
number = {1},
pages = {508--530},
doi = {10.18632/oncotarget.28747}
}
EUVIMED